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ABSTRACT: The use of a copper−iron mixed oxide as a heterogeneous
catalyst for the efficient synthesis of α-acyloxy-1,4-dioxanes and 1,4-dithianes
employing t-butyl peroxyesters is reported. The preparation and character-
ization of the catalyst are described. The effect of the heteroatoms and a
plausible mechanism are discussed. The method is operationally simple and
involves low-cost starting materials affording products in good to excellent
yields.
■ INTRODUCTION
The direct activation of C−H bonds has experienced significant
progress in the field of organic synthesis over the past decade.1
This kind of transformation poses important challenges, such as
overcoming the inert nature of most C−H bonds and the
control of site selectivity.2 Some substrates, however, present
the appropriate features for successful C−H activation. The
introduction of a new oxygenated functional group at sp3 C−H
located α to an ethereal oxygen is feasible due to the relatively
weak dissociation energy of this type of bond.3 Recently, the
preparation of α-acyloxy ethers has been studied by the Fu and
Yuan group4 and the Patel group.5
In contrast, the preparation of their α-acyloxy thioether
siblings has received scarce attention. In 1982, Szarek and
Hronowsky reported the preparation of 1,4-dithian-2-yl
benzoate in 26% yield as an intermediate in the preparation
of new pyrimidine nucleoside analogues with improved
antitumor activity as surrogates of 5-fluorouracil (5-FUra).6
To the best of our knowledge, no other α-acyloxy dithiane has
been prepared.
Previous reports focused on the synthesis of α-acyloxy ethers
have based their success on the use of transition-metal catalysts,
such as Cu7 and Fe,8 or by employing of tetrabutylammonium
iodide (TBAI)9 or N-chlorosuccinimide (NCS)10 (Scheme 2a).
Copper and iron are considered low-risk metals in terms of
supply and toxicity,11 which represents an advantage over other
metals, such as those belonging to the platinum group. In this
article, we present the use of a copper−iron mixed oxide
(CuFeOx henceforth), which effectively catalyzes the intro-
duction of an α acyloxy group to the oxygen or sulfur atoms in
1,4-dioxanes and 1,4-dithianes (Scheme 2b).
Although mixed oxides have proven to be of help in the
catalysis of oxidation reactions,12 their use in the field of organic
synthesis has been rather limited. Recently, we have reported
the allylic oxidation of alkenes and the γ-hydroxylation of
enones by employing a copper−aluminum mixed oxide.13 This
approach permits the synergistic action of two different metal
centers over a substrate. Moreover, it allows the heterogeniza-
tion of a process usually performed in a homogeneous way.
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Scheme 1. Preparation of Pyrimidine Nucleosides by Szarek
and Hronowsky
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■ RESULTS AND DISCUSSION
The preparation was carried out following our method for the
synthesis of a copper−aluminum mixed oxide (for details on
the preparation and characterization of the catalyst, see the
Supporting Information).13b,14 The reproducibility of the
CuFeOx preparation was ensured by submitting it to a
characterization process. Observations by SEM revealed that
the catalyst presented the form of a fine powder, with some
irregularities in morphology and size, but in general consisting
of micron-sized well-rounded grains. This study was
complemented by granulometric measurements, which showed
a distribution particle size in volume with relative maxima at
approximately 0.8, 9, and 40 μm that fit quite well with the size
of the particles observed by SEM. In addition, a textural study
was performed using N2 physisorption that indicated
mesoporous character of the solid.
The raw X-ray diffraction diagram of the sample showed the
presence of crystalline CuO in the tenorite phase. However, the
use of Rietveld analysis allowed for detecting other phases, such
as copper hydroxycarbonates (malachite and azurite) and spinel
CuFe2O4 mixed oxides. The relatively lower intensity of iron-
containing phases can be reasonably related to the intrinsic
limitations of the XRD technique, which prevents the detection
of amorphous phases (the synthesis method followed does not
favor obtaining crystalline materials) and underestimates iron-
related phases due to the well-known Cu Kα absorption effect
of this element. There was good agreement between composi-
tional analysis data obtained by ICP, XRF, and EDS, thus
indicating the homogeneity of the sample at both massive and
micron-surface levels (Table 1). Moreover, they are relatively
consistent with the Cu/Fe atomic ratio selected for catalyst
preparation and the formation of a copper−iron mixed oxide.
Once the catalyst was characterized, we focused on the
reaction of 1,4-dioxane 1 with either benzaldehyde 3 or benzoic
acid 5 using TBHP as the oxidant. The yields were moderate,
affording the corresponding benzoyloxy 1,4-dioxane 4 in 35 and
31% yield, respectively (Table 2, entries a and b).
Recently, Wan et al. demonstrated that treatment of an
aldehyde with TBAI and TBHP leads to the corresponding
peroxyester that is in situ used as an oxidant in a Kharasch−
Sosnovsky oxidation of an olefin.15 In our case, the treatment of
1,4-dioxane 1 and benzaldehyde 3 with TBAI in the presence of
CuFeOx was negative, leading to a mere 5% yield (Table 2,
entry c). However, when we employed t-butyl peroxybenzoate
(TBPB) as the oxidant, the reaction proceeded quantitatively
(Table 2, entry d).
To assess the efficiency of CuFeOx as a catalyst, we
subsequently tested various copper sources in our benchmark
reaction, as shown in Table 3. It was observed that, in the
absence of CuFeOx (entry 1), product 4 was formed in only
4% yield. The use of Cu(OAc)2·H2O (entry 3) resulted in 44%
yield, and the mixture of CuFeOx precursors, CuCl2, and
FeCl3·6H2O (entry 4) provided 65% yield. Other commercial
oxides and chlorides, such as Cu2O, CuO, CuCl2, and FeCl3·
6H2O (entries 5−8) were also tested, producing the desired
product in moderate yields. Entries 2 and 9−11 confirm the
important role of temperature, displaying a dramatic drop in
yield below 100 °C.
Given that the use of TBPB 6 conducted to the desired α-
benzoyloxy 1,4-dioxane 4 in quantitative yield, we thought that
Figure 1. Typical scanning electron micrograph of the CuFeOx
catalyst.
Table 1. Compositional Analysis (wt %) of the CuFeOx
Sample by Means of Induced Coupled Plasma Spectroscopy,
X-ray Fluorescence, and Energy-Dispersive X-Ray
Spectroscopy
technique Cu Fe O
ICP 47.1 ± 0.3 17.2 ± 0.1 not applicable
XRF 51.5 22.4 24.0
EDSa 52.7 ± 3.0 18.1 ± 1.5 22.2
aData correspond to the average of values obtained for four different
areas analyzed in spot mode.
Table 2. Preliminary Assaysa
aGC yield. Reaction conditions: 1,4-dioxane 1 (5.0 mmol), CuFeOx
(30 mg, 8.9 mol % Cu), CH3CN (2 mL), 140 °C, 24 h. (a)
Benzaldehyde 3 (2.5 mmol), TBHP (70% aqueous, 7.5 mmol). (b)
Benzoic acid 5 (2.5 mmol), TBHP (70% aqueous, 7.5 mmol). (c)
Benzaldehyde 3 (2.5 mmol), TBHP (70% aqueous, 7.5 mmol), TBAI
(0.5 mmol). (d) TBPB 6 (2.5 mmol).
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the use of different peroxyesters would allow us to prepare
different α-acyloxy ethers.
The report by Wan et al. mentioned above describes a facile
preparation of t-butyl peroxyesters from aldehydes catalyzed by
TBAI.15 This methodology was found to be very reproducible,
robust, and suitable for our purposes. Thus, we proceeded to
the preparation of different peroxyesters that were reacted with
1,4-dioxane 1 in the presence of CuFeOx (Table 4).
Gratifyingly, the reaction of aromatic peroxyesters furnished
the corresponding α-aryl esters 7−10 in good yields. The
nature of the group attached to the aromatic ring of the
peroxyester did not seem to affect the outcome, providing good
yields in the presence of either donor or acceptor groups. The
use of lineal t-butyl peroxyesters was also possible, as
demonstrated by the formation of 1,4-dioxan-2-yl octanoate
11. The use of t-butyl 2-thienylperoxycarboxylate led to
corresponding ester 12 in a good 73% yield. A 1-naphthyl
group could be introduced in the starting peroxyester,
providing desired product 13 in 52% yield. An interesting
case was that of the peroxyester prepared from cinnamalde-
hyde, which underwent a coupling reaction with a concomitant
decarboxylative process, furnishing 1,4-dioxane derivative 14.
This kind of transformation has been previously reported by
Li16 and Han17 groups in processes catalized by CuO and
Fe(acac)3, respectively.
The exploration of the scope continued with 1,4-dithiane 2.
Its behavior was parallel to that already described for 1,4-
dioxane 1. Thus, the respective aryl esters 15−19 were
prepared with good to excellent yields. The yields of 20 and
21 were nevertheless significantly lower than those of 11 and
12. Naphthyl derivative 22 was obtained in 53% yield, a value
similar to that obtained for 13. The main difference was
observed in the treatment with the cinnamic acid peroxyester,
where the decarboxylation was not observed, and the expected
acyloxylated 1,4-dithiane 23 was produced in 26% yield.
General inspection of Table 4 indicates that the presence of
two heteroatoms, either sulfur or oxygen, provides a suitable
system for the acyloxylation reaction to take place. We found it
convenient to evaluate the behavior of substrates bearing just
one heteroatom. The results are displayed in Table 5. Cyclic
ethers, such as tetrahydropyran 24 and tetrahydrofuran 25, led
to only traces of the corresponding benzoyloxy esters.
Additionally, linear butyl methyl ether 26 provided the
regioisomers 35a and 35b in a poor 23% overall yield (1:3.6
ratio). A slightly better yield (30%) was obtained when a linear
substrate bearing two oxygen atoms in 1,4-relative positions
(27) was used. These results suggest that the presence of two
oxygen atoms favors the reaction.
The importance of the relative location of the oxygen atoms
was investigated further (Table 5). Although 1,3-dioxane 28
and 1,3-dioxolane 29 performed poorly, 2-methyl-1,3-dioxolane
30 furnished compounds 39a−c in an overall yield of 66% (in a
13:2.5:1 ratio). This fact could be explained in terms of the
relative stability of 29 and 30 (the acetals of formaldehyde and
acetaldehyde, respectively) under the reaction conditions.
Additionally, the tertiary nature of the resulting radical
Table 3. Search for the Optimal Catalysta












aReaction conditions: 1,4-dioxane 1 (5.0 mmol), TBPB 6 (2.5 mmol),
CH3CN (2 mL), 140 °C, 24 h.
bCatalyst (30 mg, 8.9 mol % Cu, 3.7
mol % Fe). cCatalyst (8.9 mol % Cu). dCuCl2 (17 mg) and FeCl3·
6H2O (13 mg).
eCatalyst (3.7 mol % Fe). fAt 80 °C. gAt 100 °C. hAt
120 °C. iDetermined by GC.
Table 4. Scope of 1,4-Dioxane and 1,4-Dithiane Derivativesa
aGC yield is in parentheses. Reaction conditions: 1,4-dioxane 1 (5.0
mmol) or 1,4-dithiane 2 (2.0 mmol), peroxyester (2.5 mmol for 4 and
6−14 or 1.0 mmmol for 15−23), CuFeOx (30 mg, 8.9 mol % Cu for 4
and 6−14 or 12 mg, 8.9 mol % Cu for 15−23), CH3CN (2 mL) for 4
and 6−14, or CH3CN (1 mL) and CH2Cl2 (1 mL) for 15−23, 140
°C, 24 h.
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intermediate (vide infra) involved in the formation of 39a
explains this result. Eventually, the presence of two oxygen
atoms is required, preferably in a 1,4-relative position, for the
reaction to proceed properly. It is noteworthy that, in contrast
to tetrahydrofuran 25, tetrahydrothiophene 31 produced 40 in
46% yield. This seems to be in accordance with the higher
activating ability of the sulfur atom.18 This idea was supported
by the fact that 1,4-oxathiane 32 underwent acyloxylation
primarily at the α-position of the sulfur atom, leading to 41a
and 41b in a 3.7:1 ratio (70% overall yield).
The radical nature of the mechanism was confirmed by a
control reaction, employing 1,4-dioxane 1 as the substrate and
TBPB as the oxidant in the presence of 2,6-di-t-butyl-4-
methylphenol (BHT), which led to the formation of 4 in just
2% yield.
Although CuFeOx presents a multicomponent nature, which
makes it difficult to precisely define the origin of its activity,
there are precedents of the use of copper−iron mixed oxides,
such as CuFe2O4 in heterogeneous conditions in oxidative
couplings.19 A proposed, plausible mechanism is depicted in
Scheme 3. Decomposition of TBPB can be favored by the
presence of the metallic centers (A). The solid provides a
surface suitable for the formation of radicals and the encounter
of the different species (B). The presence of the t-butoxyl
radical would induce the formation of the radical at the α-
position of the ether or thiother (C). The higher yields
obtained when two heteroatoms are present in the ether or the
thioether suggest the coordination of one of these heteroatoms
to a metallic center. The other oxygen or sulfur atom would
activate its contiguous position by electron donation to the σ*
orbital of the C−H bond.20 The possibility of backbonding
from the metal to the sulfur atom21 would explain that one
sulfur atom is enough for the reaction to proceed in contrast to
when only one oxygen atom is present. Once the radical is
formed, coupling with the acyloxy moiety would take place,
affording the corresponding product (D).
■ CONCLUSION
This work is an interesting example of the use of mixed oxides
as catalysts for the activation of C−H bonds. In particular, the
acyloxylation at the α-position of ethers and thioethers can be
performed employing copper−iron mixed oxides in an efficient
and clean way. In addition, there are limited precedents of the
use of organic peroxides in heterogeneous catalysis.22
Conversely, although acyloxylation of 1,4-ethers has recently
been studied, the use of the related 1,4-thioethers has not been
reported with the exception of the Szarek and Hrownosky
paper.6 Last, but not least important, the presence of sulfur
atoms in a substrate generally restricts the use of metallic
catalysts due to catalyst poisoning.23 This fact limits the
application of C−H activation reactions in the search of sulfur-
based heterocyclic drugs. In this sense, the use of copper−iron
mixed oxides provides an efficient alternative to overcome this
problem.
■ EXPERIMENTAL SECTION
General Information. NMR spectra were recorded on 400 or 500
MHz spectrometers using standard pulse sequences. Spectra were
referenced to the internal chloroform (CHCl3, δ = 7.25 ppm for
1H
NMR, δ = 77.0 ppm for 13C NMR). GC analyses were performed
using a DB-5 column. Octadecane was employed as an internal
standard, and analyses were run in triplicate. Reactions were
monitored through TLC on commercial silica gel plates precoated
with silica gel. Visualization of the developed plate was performed by
fluorescence quenching and aqueous ceric ammonium molybdate or
anisaldehyde stains. HPLC purification was carried out using a 1 × 25
cm silica gel column (10 μm particle size). Fourier transform infrared
spectroscopy (FTIR) spectra were recorded using NaCl plates, and
data are reported in cm−1. Mass spectra were recorded on a UPLC-
QTOF mass spectrometer.
Compositional analysis of the copper−iron mixed oxide was studied
by means of both inductively coupled plasma atomic emission
spectroscopy (ICP-AES) and X-ray fluorescence (XRF). Textural
characteristics were investigated by means of N2 physisorption at −196
°C. The experiment was performed with a sample that was first
subjected to a heat treatment under high vacuum at 150 °C for 2 h.
The recorded isotherms were used to obtain the specific surface area,
SBET, and the porosity using the BET and BJH data treatment,
respectively. Scanning electron microscopy (SEM) images and energy
dispersive spectroscopy (EDS) compositional data were obtained with
Table 5. Role of the Substitution Pattern in the Ether or
Thioethera,b
aReaction conditions: ethers 24−30 (5.0 mmol), tetrahydrothiophene
31 (2.0 mmol) or 1,4-oxathiane 32 (5.0 mmol) and TBPB (2.5 mmol
for 24−30 and 32 or 1.0 mmmol for 31), CuFeOx (30 mg, 8.9 mol %
Cu for 24−30 and 32 or 12 mg, 8.9 mol % Cu for 31), CH3CN (2
mL) for 24−30 or CH3CN (1 mL) and CH2Cl2 (1 mL) for 31 and 32,
140 °C, 24 h. bGC yield is in parentheses. c35a and 35b formed in the
same reaction (23% overall yield). d39a−c formed in the same
reaction (66% overall yield). e41a and 41b formed in the same
reaction (70% overall yield).
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a scanning electron microscope using a nominal resolution of 3 nm.
Particle size distribution was obtained employing a granulometer
operating with laser diffraction over a previously centrifuged dispersion
of the sample (3 min sonicated) in water. Results were obtained from
the average of the three tests performed to ensure reproducibility of
the measurements. Structural studies were carried out with X-ray
diffraction (XRD) at room temperature using a powder diffractometer
operating with Cu Kα radiation. The 2θ angle ranged from 3° to 75°
with a step of 0.05° and a counting time of 1 s. The Rietveld method
was applied to the XRD data using the FULLPROF program.24
Catalyst Preparation.13b The preparation of the copper−iron
mixed oxide (CuFeOx) was carried out following our method for the
synthesis of copper−aluminum mixed oxide, which is based on that
described by Guida et al.14 for the synthesis of hydrotalcites. To this
end, a solution of Na2CO3 (1.27 g) and NaOH (5.20 g) in water (100
mL) was added dropwise for 1.5 h over a solution containing CuCl2
(5.00 g) and FeCl3·6H2O (4.00 g) in water (50 mL). The suspension
turned dark brown, and it was stirred at 70 °C for 22 h. The mixture
was then filtered, and the precipitate was washed with warm water (3
× 200 mL). The solid was dried in an oven at 105 °C for 24 h, after
which time it was ground until a fine powder was obtained. The solid
was left exposed to air for 72 h prior to use.
General Procedure for the Synthesis of Peroxyesters. All
peroxyesters have been prepared according to the literature
procedure.15 The following two peroxyesters have been synthesized
for the first time:
(E)-t-Butyl 3-Phenylprop-2-eneperoxoate. Colorless oil (894 mg,
20%); 1H NMR (400 MHz, CDCl3) δ 7.60 (d, J = 16.0 Hz, 1H), 7.36
(dd, J = 6.7, 2.9 Hz, 2H), 7.25−7.21 (m, 3H), 6.27 (d, J = 16.0 Hz,
1H), 1.24 (s, 9H); 13C{1H} NMR (100 MHz, CDCl3) δ 164.7, 145.5,
133.5, 130.3, 128.5, 127.7, 112.7, 83.1, 25.7; IR (film) νmax 3063, 2936,
2983, 1755, 1634, 1450, 1367, 1190, 1108, 980, 763 cm−1; HRMS
(ESI) calcd for C13H16O3Na [M + Na]
+ 243.0997, found 243.0997.
t-Butyl Octaneperoxoate. Colorless oil (804 mg, 18%); 1H NMR
(400 MHz, CDCl3) δ 2.28 (t, J = 7.5 Hz, 2H), 1.64 (tt, J = 7.5, 7.5 Hz,
2H), 1.30 (s, 9H), 1.29−1.20 (m, 8H), 0.85 (t, J = 6.9 Hz, 3H);
13C{1H} NMR (100 MHz, CDCl3) δ 171.1, 83.2, 31.6, 31.3, 29.0, 28.8,
26.1, 25.0, 22.5, 14.0; IR (film) νmax 2957, 2930, 2859, 1779, 1467,
1367, 1191, 854 cm−1; HRMS (ESI) calcd for C8H15O3 [M − tBu]−
159.1021, found 159.1015.
General Procedure for the Acyloxylation of Ethers and 1,4-
Oxathiane. Thirty milligrams of CuFeOx was suspended in 2 mL of
acetonitrile in a sealed tube, and the tube was stirred for 5 min. Then,
ether (5.0 mmol) and t-butyl peroxyester (2.5 mmol) were added, and
the reaction mixture was stirred at 140 °C. Caution! Considerable
pressure can develop. After 24 h, an aliquot was taken and analyzed by
GC (using octadecane as an internal standard). The solvent was
evaporated under reduced pressure, and the crude product was
purified by SEPHADEX column chromatography with methanol as the
eluent. For 1,4-oxathiane, 2 mL of acetonitrile/dichloromethane (1:1)
was employed as the solvent.
General Procedure for the Acyloxylation of Thioethers.
Twelve milligrams of CuFeOx was suspended in 1 mL of acetonitrile
in a sealed tube, and the tube was stirred for 5 min. Then, thioether
(2.0 mmol) and t-butyl peroxyester (1.0 mmol, dissolved in 1 mL of
dichloromethane) were added, and the reaction mixture was stirred at
140 °C. Caution! Considerable pressure can develop. After 24 h, an
aliquot was taken and analyzed by GC (using octadecane as an internal
standard). The solvent was evaporated under reduced pressure, and
the crude product was purified by silica gel column chromatography
with a mixture of EtOAc/hexanes as the eluent.
1,4-Dioxan-2-yl Benzoate (4). Colorless oil (380 mg, 73%); 1H
NMR (500 MHz, CDCl3) δ 8.11 (d, J = 7.6 Hz, 2H), 7.58 (tt, J = 7.5,
1.8 Hz, 1H), 7.45 (dd, J = 7.9, 7.9 Hz, 2H), 6.09 (br s, 1H), 4.21 (ddd,
J = 11.8, 6.6, 6.6 Hz, 1H), 3.89−3.87 (m, 2H), 3.83−3.80 (m, 2H),
3.66 (ddd, J = 5.2, 2.6, 2.6 Hz, 1H); 13C{1H} NMR (126 MHz,
CDCl3) δ 165.2, 133.3, 129.9, 129.7, 128.4, 89.8, 67.8, 66.1, 61.7; IR
(film) νmax 2973, 2858, 1731, 1601, 1453, 1259, 1155, 881, 711 cm
−1;
HRMS (ESI) calcd for C11H12O4Na [M + Na]
+ 231.0633, found
231.0640.
1,4-Dioxan-2-yl 4-Methylbenzoate (7). Yellowish oil (450 mg,
81%); 1H NMR (400 MHz, CDCl3) δ 8.00 (d, J = 8.1 Hz, 2H), 7.25
(d, J = 8.0 Hz, 2H), 6.07 (br s, 1H), 4.20 (ddd, J = 12.0, 6.5, 6.5 Hz,
1H), 3.89−3.86 (m, 2H), 3.83−3.79 (m, 2H), 3.66 (ddd, J = 5.3, 2.6,
2.6 Hz, 1H), 2.41 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ 165.3,
144.2, 129.9, 129.1, 126.9, 89.6, 67.9, 66.1, 61.8, 21.7; IR (film) νmax
2974, 2857, 1726, 1612, 1277, 1087, 883, 754 cm−1; HRMS (ESI)
calcd for C12H13O4 [M − H]− 221.0814, found 221.0818.
1,4-Dioxan-2-yl 4-Methoxybenzoate (8). White amorphous
solid (506 mg, 85%); 1H NMR (400 MHz, CDCl3) δ 8.05 (d, J = 9.0
Hz, 2H), 6.91 (d, J = 9.0 Hz, 2H), 6.05 (br s, 1H), 4.18 (ddd, J = 11.8,
5.5, 5.5 Hz, 1H), 3.86−3.85 (m, 2H), 3.84 (s, 3H), 3.81−3.78 (m,
2H), 3.65 (ddd, J = 5.3, 2.7, 2.7 Hz, 1H); 13C{1H} NMR (100 MHz,
CDCl3) δ 164.9, 163.7, 132.0, 122.0, 113.7, 89.5, 67.9, 66.1, 61.8, 55.4;
IR (film) νmax 2972, 2856, 1720, 1607, 1512, 1257, 1170, 1088, 1020,
913, 883, 771 cm−1; HRMS (ESI) calcd for C12H14O5Na [M + H]
+
261.0739, found 261.0736.
1,4-Dioxan-2-yl 4-Chlorobenzoate (9). White amorphous solid
(504 mg, 83%); 1H NMR (400 MHz, CDCl3) δ 8.04 (d, J = 8.8 Hz,
2H), 7.42 (d, J = 8.8 Hz, 2H), 6.07 (br s, 1H), 4.19 (ddd, J = 11.8, 6.6,
6.6 Hz, 1H), 3.88−3.87 (m, 2H), 3.83−3.81 (m, 2H), 3.67 (ddd, J =
5.1, 2.6, 2.6 Hz, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ 164.4,
139.9, 131.2, 128.8, 128.1, 90.0, 67.7, 66.1, 61.8; IR (film) νmax 2960,
2856, 1718, 1594, 1236, 1152, 1087, 882, 758 cm−1; HRMS (ESI)
calcd for C11H10O4
35Cl [M − H]− 241.0268, found 241.0258; calcd for
C11H10O4
37Cl [M − H]− 243.0238, found 243.0250.
1,4-Dioxan-2-yl 4-Bromobenzoate (10). White amorphous
solid (567 mg, 79%); 1H NMR (400 MHz, CDCl3) δ 7.97 (d, J =
8.8 Hz, 2H), 7.59 (d, J = 8.8 Hz, 2H), 6.07 (br s, 1H), 4.19 (ddd, J =
13.3, 6.6, 6.6 Hz, 1H), 3.88−3.86 (m, 2H), 3.83−3.81 (m, 2H), 3.67
(ddd, J = 5.2, 2.6, 2.6 Hz, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ
164.5, 131.8, 131.4, 128.6, 90.0, 67.8, 66.1, 61.8; IR (film) νmax 2974,
2863, 1727, 1589, 1260, 1068, 880, 746 cm−1; HRMS (ESI) calcd for
Scheme 3. Plausible Mechanism
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C11H11O4
79BrNa [M + Na]+ 308.9738, found 308.9749; calcd for
C11H11O4
81BrNa [M + Na]+ 310.9718, found 308.9756.
1,4-Dioxan-2-yl Octanoate (11). Yellow oil (294 mg, 51%); 1H
NMR (400 MHz, CDCl3) δ 5.83 (br s, 1H), 4.08 (ddd, J = 12.3, 6.5,
6.5 Hz, 1H), 3.78−3.66 (m, 4H), 3.60 (ddd, J = 5.5, 2.8, 2.8 Hz, 1H),
2.36 (t, J = 7.6 Hz, 2H), 1.63 (tt, J = 14.5, 14.5 Hz, 3H), 1.31−1.19
(m, 8H), 0.85 (t, J = 6.7 Hz, 3H). 13C{1H} NMR (100 MHz, CDCl3)
δ 172.5, 89.0, 67.7, 66.0, 61.7, 34.3, 31.6, 29.0, 28.8, 24.7, 22.5, 14.0. IR
(film) νmax 2958, 2930, 2857, 1747, 1456, 1232, 1147, 1069, 917, 856,
756 cm−1; HRMS (ESI) calcd for C12H21O4 [M − H]− 229.1440,
found 229.1441.
1,4-Dioxan-2-yl-thiophene-2-carboxylate (12). Yellow oil (391
mg, 73%); 1H NMR (400 MHz, CDCl3) δ 7.88 (dd, J = 3.8, 1.3 Hz,
1H), 7.59 (dd, J = 5.0, 1.3 Hz, 1H), 7.11 (dd, J = 5.0, 3.8 Hz, 1H), 6.04
(br s, 1H), 4.20 (ddd, J = 11.8, 7.1, 5.9 Hz, 1H), 3.86−3.85 (m, 2H),
3.81−3.79 (m, 2H), 3.65 (ddd, J = 5.3, 2.6, 2.6 Hz, 1H); 13C{1H}
NMR (100 MHz, CDCl3) δ 160.8, 134.1, 133.2, 127.8, 89.9, 67.7, 66.0,
61.8; IR (film) νmax 3103, 2975, 2858, 1715, 1418, 1256, 1062, 1013,
909, 750 cm−1; HRMS (ESI) calcd for C9H9O4S [M − H]− 213.0222,
found 213.0226.
1,4-Dioxan-2-yl 1-Naphthoate (13). White amorphous solid
(336 mg, 52%); 1H NMR (400 MHz, CDCl3) δ 9.02 (d, J = 8.7 Hz,
1H), 8.35 (dd, J = 7.3, 1.3 Hz, 1H), 8.04 (d, J = 8.2 Hz, 1H), 7.88 (d, J
= 8.2 Hz, 1H), 7.63 (ddd, J = 8.4, 8.4, 1.4 Hz, 1H), 7.54 (ddd, J = 8.1,
6.9, 1.2 Hz, 1H), 7.51 (dd, J = 8.2, 7.4 Hz, 1H), 6.21 (br s, 1H), 4.26
(ddd, J = 11.8, 6.2, 6.2 Hz, 1H), 3.96−3.95 (m, 2H), 3.86−3.83 (m,
2H), 3.71 (ddd, J = 5.2, 2.6, 2.6 Hz, 1H); 13C{1H} NMR (100 MHz,
CDCl3) δ 165.8, 134.0, 133.8, 131.5, 130.9, 128.5, 128.0, 126.2, 126.1,
125.7, 124.4, 89.8, 67.9, 66.1, 61.8; IR (film) νmax 2973, 2856, 1721,
1510, 1233, 1131, 1067, 883, 783 cm−1; HRMS (ESI) calcd for
C15H13O4 [M − H]− 257.0814, found 257.0815.
2-Styryl-1,4-dioxane (14). Yellowish amorphous solid (128 mg,
27%); 1H NMR (500 MHz, CDCl3) δ 7.38 (d, J = 7.1 Hz, 2H), 7.31
(t, J = 7.5 Hz, 2H), 7.25 (tt, J = 6.5, 1.3 Hz, 1H), 6.69 (d, J = 16.1 Hz,
1H), 6.09 (dd, J = 16.1, 6.2 Hz, 1H), 4.25 (dddd, J = 10.1, 6.2, 2.8, 1.4
Hz, 1H), 3.89−3.80 (m, 3H), 3.75 (br dd, J = 11.6, 2.6 Hz, 1H), 3.66
(ddd, J = 11.5, 10.8, 3.2 Hz, 1H), 3.42 (dd, J = 11.5, 10.0 Hz, 1H);
13C{1H} NMR (126 MHz, CDCl3) δ 136.3, 132.6, 128.5, 127.8, 126.5,
125.1, 76.0, 70.9, 66.6, 66.3; IR (film) νmax 3026, 2968, 2868, 1452,
1118, 967, 923, 870, 746, 695 cm−1; HRMS (ESI) calcd for C12H15O2
[M + H]+ 191.1072, found 191.1079.
1,4-Dithian-2-yl Benzoate (15). Yellowish amorphous solid (192
mg, 80%); 1H NMR (400 MHz, CDCl3) δ 8.14 (dd, J = 8.4, 1.4 Hz,
2H), 7.58 (tt, J = 6.8, 1.3 Hz, 1H), 7.46 (dd, J = 7.8, 7.8 Hz, 2H), 6.06
(dd, J = 5.0, 1.9 Hz, 1H), 3.44−3.37 (m, 2H), 3.10 (dd, J = 11.7, 11.7
Hz, 1H), 3.01 (dd, J = 14.2, 5.1 Hz, 1H), 2.81−2.70 (m, 2H); 13C{1H}
NMR (100 MHz, CDCl3) δ 164.9, 133.3, 129.8, 129.7, 128.4, 67.7,
33.5, 28.0, 26.2; IR (film) νmax 3063, 2911, 1721, 1601, 1451, 1324,
1265, 1095, 1069, 965, 917, 710 cm−1; HRMS (ESI) calcd for
C11H12O2S2Na [M + Na]
+ 263.0176, found 263.0145.
1,4-Dithian-2-yl 4-Methylbenzoate (16). White amorphous
solid (226 mg, 89%); 1H NMR (500 MHz, CDCl3) δ 8.03 (d, J =
8.2 Hz, 2H), 7.26 (d, J = 7.9 Hz, 2H), 6.06 (br s, 1H), 3.41 (br s, 2H),
3.04 (br s, 2H), 2.77 (br s, 2H), 2.41 (s, 3H); 13C{1H} NMR (126
MHz, CDCl3): δ 165.0, 144.1, 129.9, 129.2, 127.1, 68.1, 38.7, 28.1,
23.0, 21.7; IR (film) νmax 2913, 1718, 1612, 1265, 1092, 914, 749
cm−1; HRMS (ESI) calcd for C12H14O2S2Na [M + Na]
+ 277.0333,
found 277.0340.
1,4-Dithian-2-yl 4-Methoxybenzoate (17). White amorphous
solid (224 mg, 83%); 1H NMR (500 MHz, CDCl3) δ 8.09 (d, J = 9.0
Hz, 2H), 6.93 (d, J = 8.9 Hz, 2H), 6.04 (br d, J = 3.7 Hz, 1H), 3.85 (s,
3H), 3.42−3.37 (m, 2H), 3.10−2.98 (m, 2H), 2.79−2.72 (m, 2H);
13C{1H} NMR (126 MHz, CDCl3) δ 164.6, 163.7, 131.9, 122.1, 113.7,
67.6, 55.4, 33.6, 28.1, 26.3; IR (film) νmax 2913, 2839, 1715, 1606,
1511, 1258, 1093, 1029, 967, 847, 769 cm−1; HRMS (ESI) calcd for
C12H14O3S2Na [M + Na]
+ 293.0282, found 293.0288.
1,4-Dithian-2-yl 4-Chlorobenzoate (18). Yellowish amorphous
solid (234 mg, 85%); 1H NMR (500 MHz, CDCl3) δ 8.07 (d, J = 8.8
Hz, 2H), 7.43 (d, J = 8.8 Hz, 2H), 6.05 (br d, J = 4.9 Hz, 1H), 3.44−
3.37 (m, 2H), 3.10 (dd, J = 12.5, 12.5 Hz, 1H), 3.00 (dd, J = 14.2, 5.0
Hz, 1H), 2.81−2.71 (m, 2H); 13C{1H} NMR (126 MHz, CDCl3) δ
164.1, 139.8, 131.2, 128.8, 128.2, 68.1, 33.5, 28.1, 26.2; IR (film) νmax
2956, 2913, 1723, 1594, 1264, 1092, 1014, 964, 915, 757 cm−1; HRMS
(ESI) calcd for C11H11O2S2
35ClNa [M + Na]+ 296.9787, found
296.9790; calcd for C11H11O2S2
37ClNa [M + Na]+ 298.9757, found
298.9755.
1,4-Dithian-2-yl 4-Bromobenzoate (19). White amorphous
solid (287 mg, 90%); 1H NMR (500 MHz, CDCl3) δ 8.00 (d, J =
8.7 Hz, 2H), 7.60 (d, J = 8.7 Hz, 2H), 6.05 (br d, J = 3.6 Hz, 1H),
3.42−3.37 (m, 2H), 3.15−2.93 (m, 2H), 2.87−2.73 (m, 2H); 13C{1H}
NMR (126 MHz, CDCl3) δ 164.3, 131.8, 131.4, 128.7, 128.6, 68.2,
33.4, 28.0, 26.3; IR (film) νmax 2912, 1725, 1590, 1398, 1263, 1096,
1011, 963, 753 cm−1; HRMS (ESI) calcd for C7H4O2
79Br [M −
C4H7S2]
− 198.9395, found 198.9391; calcd for C7H4O2
81Br [M −
C4H7S2]
− 200.9374, found 200.9372.
1,4-Dithian-2-yl Octanoate (20). Yellow oil (60 mg, 23%); 1H
NMR (500 MHz, CDCl3) δ 5.82 (dd, J = 5.2, 1.9 Hz, 1H), 3.33−3.27
(m, 2H), 3.10−2.97 (m, 1H), 2.88 (dd, J = 14.1, 5.2 Hz, 1H), 2.76−
2.69 (m, 2H), 2.39 (t, J = 7.6 Hz, 2H), 1.65 (tt, J = 14.7, 14.7 Hz, 2H),
1.31−1.25 (m, 8H), 0.87 (t, J = 5.2 Hz, 3H); 13C{1H} NMR (126
MHz, CDCl3) δ 172.4, 67.4, 34.4, 33.3, 31.6, 29.0, 28.9, 28.0, 26.3,
24.9, 22.6, 14.0; IR (film) νmax 2955, 2927, 2857, 1740, 1466, 1153,
966, 725 cm−1; HRMS (ESI) calcd for C12H22O2S2Na [M + Na]
+
285.0959, found 285.0954.
1,4-Dithian-2-yl Thiophene-2-carboxylate (21). Yellowish
amorphous solid (101 mg, 41%); 1H NMR (500 MHz, CDCl3) δ
7.90 (dd, J = 3.8, 1.3 Hz, 1H), 7.60 (dd, J = 5.0, 1.3 Hz, 1H), 7.12 (dd,
J = 5.0, 3.8 Hz, 1H), 6.03−6.01 (m, 1H), 3.42−3.37 (m, 2H), 3.08
(dd, J = 11.8, 11.8 Hz, 1H), 3.00 (dd, J = 14.2, 5.2 Hz, 1H), 2.80−2.71
(m, 2H). 13C{1H} NMR (126 MHz, CDCl3) δ 160.6, 134.1, 133.2,
133.1, 127.8, 68.2, 33.4, 28.0, 26.3; IR (film) νmax 3099, 2911, 1709,
1523, 1416, 1253, 1072, 961, 744 cm−1; HRMS (ESI) calcd for
C9H10O2S3Na [M + Na]
+ 268.9741, found 268.9734.
1,4-Dithian-2-yl 1-Naphthoate (22). Yellowish amorphous solid
(154 mg, 53%); 1H NMR (500 MHz, CDCl3) δ 9.05 (d, J = 8.7 Hz,
1H), 8.40 (dd, J = 7.3, 1.3 Hz, 1H), 8.05 (d, J = 8.2 Hz, 1H), 7.90−
7.88 (m, 1H), 7.64 (ddd, J = 8.6, 5.6, 1.4 Hz, 1H), 7.56−7.52 (m, 2H),
6.20−6.19 (m, 1H), 3.50−3.43 (m, 2H), 3.16−3.09 (m, 2H), 2.83−
2.75 (m, 2H); 13C{1H} NMR (126 MHz, CDCl3) δ 165.7, 133.9,
133.8, 131.4, 131.1, 128.6, 128.0, 126.3, 126.3, 125.8, 124.5, 68.1, 33.6,
28.1, 26.3; IR (film) νmax 3051, 2911, 1716, 1510, 1237, 1191, 1126,
995, 780 cm−1; HRMS (ESI) calcd for C15H14O2S2Na [M + Na]
+
313.0333, found 313.0347.
1,4-Dithian-2-yl Cinnamate (23). Yellow amorphous solid (69
mg, 26%); 1H NMR (500 MHz, CDCl3) δ 7.78 (d, J = 16.0 Hz, 1H),
7.56−7.54 (m, 2H), 7.40−7.38 (m, 3H), 6.53 (d, J = 16.0 Hz, 1H),
5.97 (dd, J = 5.2, 2.0 Hz, 1H), 3.40−3.35 (m, 2H), 3.07 (dd, J = 11.5,
11.5 Hz, 1H), 2.98 (dd, J = 14.2, 5.2 Hz, 1H), 2.80−2.72 (m, 2H);
13C{1H} NMR (126 MHz, CDCl3) δ 165.4, 146.0, 134.2, 130.5, 128.9,
128.2, 117.4, 67.7, 33.4, 28.0, 26.3; IR (film) νmax 3060, 2911, 1713,
1636, 1336, 1151, 977, 768 cm−1; HRMS (ESI) calcd for
C13H14O2S2Na [M + Na]
+ 289.0333, found 289.0342.
1-Methoxybutyl Benzoate and Butoxymethyl Benzoate (35a
and 35b) (Mixture of Regioisomers). Colorless oil (120 mg, 23%);
1H NMR (500 MHz, CDCl3) δ 8.12−8.03 (m, 4H), 7.59−7.54 (m,
2H), 7.48−7.42 (m, 4H), 6.02 (t, J = 5.4 Hz, 1H), 5.54 (s, 2H), 3.72
(t, J = 6.6 Hz, 2H), 3.47 (s, 3H), 1.83−1.79 (m, 2H), 1.64−1.58 (m,
2H), 1.51−1.44 (m, 2H), 1.42−1.35 (m, 2H), 0.96 (t, J = 7.4 Hz, 3H),
0.91 (t, J = 7.4 Hz, 3H); 13C{1H} NMR (126 MHz, CDCl3) δ 166.3,
166.0, 133.1, 133.1, 130.1, 129.95, 129.7, 129.5, 128.4, 128.4, 100.4,
90.0, 70.4, 56.7, 36.5, 31.5, 19.1, 17.3, 13.8, 13.7; HRMS (ESI) calcd
for C12H16O3Na [M + Na]
+ 231.0997, found 231.0994 for 35a; calcd
for C12H16O3Na [M + Na]
+ 231.0997, found 231.0993 for 35b.
1,2-Dimethoxyethyl Benzoate (36). Colorless oil (158 mg,
30%); 1H NMR (500 MHz, CDCl3) δ 8.07 (dd, J = 8.4, 1.3 Hz, 2H),
7.56 (tt, J = 7.4, 7.4 Hz, 1H), 7.43 (dd, J = 8.0, 7.6 Hz, 2H), 6.12 (dd, J
= 5.2, 4.6 Hz, 1H), 3.62 (dd, J = 10.7, 5.3 Hz, 1H), 3.59 (dd, J = 10.7,
4.6 Hz, 1H), 3.52 (s, 3H), 3.41 (s, 3H); 13C{1H} NMR (126 MHz,
CDCl3) δ 166.0, 133.3, 129.8, 129.5, 128.3, 97.4, 72.7, 59.5, 57.1; IR
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(film) νmax 2940, 1724, 1452, 1273, 1093, 926, 713 cm
−1; HRMS
(ESI) calcd for C11H14O4Na [M + Na]
+ 233.0790, found 233.0783.
1,3-Dioxolan-4-yl Benzoate (38). Colorless oil (73 mg, 15%);
1H NMR (500 MHz, CDCl3) δ 8.04 (d, J = 8.4 Hz, 2H), 7.59−7.56
(m, 1H), 7.43 (dd, J = 8.0, 8.0 Hz, 2H), 6.58 (dd, J = 4.1, 1.9 Hz, 1H),
5.19 (br s, 1H), 5.15 (br s, 1H), 4.17 (dd, J = 9.5, 4.2 Hz, 1H), 4.12
(dd, J = 9.5, 1.9 Hz, 1H); 13C{1H} NMR (126 MHz, CDCl3) δ 165.8,
133.5, 129.8, 129.4, 128.4, 95.9, 94.6, 70.7; IR (film) νmax 2881, 1728,
1452, 1271, 1092, 922, 712 cm−1; HRMS (ESI) calcd for C10H10O4Na
[M + Na]+ 217.0477, found 217.0470.
2-Methyl-1,3-dioxolan-2-yl Benzoate (39a). Colorless oil (270
mg, 52%); 1H NMR (400 MHz, CDCl3) δ 8.00 (dd, J = 8.4, 1.4 Hz,
2H), 7.52 (tt, J = 6.8, 1.3 Hz, 1H), 7.39 (dd, J = 7.8, 7.8 Hz, 2H),
4.48−4.46 (m, 2H), 4.38−4.35 (m, 2H), 2.04 (s, 3H); 13C{1H} NMR
(120 MHz, CDCl3) δ 170.6, 166.1, 133.0, 129.6, 129.5, 128.2, 62.5,
62.0, 20.6; IR (film) νmax 2960, 1743, 1722, 1452, 1375, 1278, 1232,
1062, 712 cm−1; HRMS (ESI) calcd for C11H12O4Na [M + Na]
+
231.0633, found 231.0628.
trans-2-Methyl-1,3-dioxolan-4-yl Benzoate (39b). Colorless
oil (52 mg, 10%); 1H NMR (400 MHz, CDCl3) δ 8.04 (dd, J = 8.4, 1.3
Hz, 2H), 7.58 (tt, J = 6.9,1.3 Hz, 1H), 7.44 (dd, J = 8.0, 8.0 Hz, 2H),
6.57 (dd, J = 4.8, 2.7 Hz, 1H), 5.37 (q, J = 4.8 Hz, 1H), 4.37 (dd, J =
9.5, 4.8 Hz, 1H), 4.01 (dd, J = 9.5, 2.7 Hz, 1H), 1.45 (d, J = 4.9 Hz,
3H); 13C{1H} NMR (100 MHz, CDCl3) δ 165.8, 133.5, 129.8, 129.5,
128.4, 102.4, 95.5, 71.0, 19.2; IR (film) νmax 2994, 2894, 1729, 1452,
1272, 1158, 1057, 981, 712 cm−1; HRMS (ESI) calcd for C11H12O4Na
[M + Na]+ 231.0633, found 231.0626.
cis-2-Methyl-1,3-dioxolan-4-yl Benzoate (39c). Colorless oil
(21 mg, 4%); 1H NMR (400 MHz, CDCl3) δ 8.05 (dd, J = 8.4, 1.3 Hz,
2H), 7.58 (tt, J = 6.9,1.3 Hz, 1H), 7.45 (dd, J = 7.9, 7.9 Hz, 2H), 6.52
(d, J = 3.6 Hz, 1H), 5.31 (q, J = 4.9 Hz, 1H), 4.32 (d, J = 9.8 Hz, 1H),
4.02 (dd, J = 9.8, 3.7 Hz, 1H), 1.51 (d, J = 4.9 Hz, 3H); 13C{1H} NMR
(100 MHz, CDCl3) δ 165.9, 133.4, 129.8, 129.7, 128.4, 104.6, 94.9,
71.6, 21.2; IR (film) νmax 2999, 2884, 1726, 1272, 1157, 1067, 1024,
981, 712 cm−1; HRMS (ESI) calcd for C11H12O4Na [M + Na]
+
231.0633, found 231.0634.
Tetrahydrothiophen-2-yl Benzoate (40). Yellowish amorphous
solid (96 mg, 46%); 1H NMR (500 MHz, CDCl3) δ 8.01 (dd, J = 8.3,
1.2 Hz, 2H), 7.56−7.52 (m, 1H), 7.43−7.40 (m, 2H), 6.42 (dd, J =
4.8, 1.4 Hz, 1H), 3.07 (ddd, J = 9.8, 7.1, 2.3 Hz, 1H), 2.86 (ddd, J =
10.4, 10.4, 6.2 Hz, 1H), 2.46−2.42 (m, 1H), 2.31−2.24 (m, 1H),
2.21−2.11 (m, 1H), 2.06−1.98 (m, 1H); 13C{1H} NMR (126 MHz,
CDCl3) δ 166.0, 133.0, 130.1, 129.6, 128.3, 83.6, 37.4, 32.4, 28.4; IR
(film) νmax 2961, 2936, 1717, 1451, 1269, 1096, 1025, 921, 710 cm
−1;
HRMS (ESI) calcd for C11H12O2SNa [M + Na]
+ 231.0456, found
231.0453.
1,4-Oxathian-3-yl Benzoate (41a). White amorphous solid (308
mg, 55%); 1H NMR (500 MHz, CDCl3) δ 8.12 (dd, J = 8.4, 1.3 Hz,
2H), 7.57 (tt, J = 7.4, 1.3 Hz, 1H), 7.45 (dd, J = 7.8, 7.8 Hz, 2H), 5.79
(br s, 1H), 4.27 (br s, 1H), 4.24 (br s, 1H), 4.02 (dd, J = 12.6, 1.7 Hz,
1H), 3.86 (ddd, J = 11.8, 11.8, 2.0 Hz, 1H), 3.39−3.34 (m, 1H), 2.30
(br d, J = 13.6 Hz, 1H); 13C{1H} NMR (126 MHz, CDCl3) δ 165.35,
133.3, 129.9, 129.8, 128.4, 71.2, 68.7, 68.0, 23.5; IR (film) νmax 3063,
2952, 2854, 1719, 1451, 1262, 1097, 1008, 711 cm−1; HRMS (ESI)
calcd for C11H12O3SNa [M + Na]
+ 247.0405, found 247.0404.
1,4-Oxathian-2-yl Benzoate (41b). White amorphous solid (84
mg, 15%); 1H NMR (500 MHz, CDCl3) δ 8.10 (dd, J = 8.4, 1.3 Hz,
2H), 7.58−7.56 (m, 1H), 7.45 (dd, J = 7.7., 7.7 Hz, 2H), 6.17 (br s,
1H), 4.35 (br s, 1H), 4.01 (br s, 1H), 2.83 (br s, 2H), 2.64 (br s, 2H);
13C{1H} NMR (126 MHz, CDCl3) δ 164.7, 133.4, 129.86, 129.5,
128.4, 91.2, 66.0, 29.5, 25.8; IR (film) νmax 3063, 2920, 1728, 1452,
1269, 1062, 955 cm−1; HRMS (ESI) calcd for C11H12O3SNa [M +
Na]+ 247.0405, found 247.0402.
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T.; Liu, F.; Glorius, F. Chem. Soc. Rev. 2011, 40, 4740−4761.
(2) (a) White, M. C. Synlett 2012, 23, 2746−2748. (b) Lyons, T. W.;
Sanford, M. S. Chem. Rev. 2010, 110, 1147−1169. (c) Giri, R.; Shi, B.-
F.; Engle, K. M.; Maugel, N.; Yu, J.-Q. Chem. Soc. Rev. 2009, 38, 3242−
3272.
(3) (a) Krylov, I. B.; Vil’, V. A.; Terent’ev, A. A. Beilstein J. Org. Chem.
2015, 11, 92−146. (b) Zhao, J.; Fang, H.; Zhou, W.; Han, J.; Pan, Y.
Org. Chem. 2014, 79, 3847−3855. (c) Majji, G.; Guin, S.; Rout, S. K.;
Behera, A.; Patel, B. K. Chem. Commun. 2014, 50, 12193−12196.
(4) Wang, Q.; Zheng, H.; Chai, W.; Chen, D.; Zeng, X.; Fu, R.; Yuan,
R. Org. Biomol. Chem. 2014, 12, 6549−6553.
(5) Rout, S. K.; Guin, S.; Ali, W.; Gogoi, A.; Patel, B. K. Org. Lett.
2014, 16, 3086−3089.
(6) (a) Hronowski, L. J. J.; Szarek, W. A. J. Med. Chem. 1982, 25,
522−526. (b) Sosnovsky, G.; Yang, N. C. J. Org. Chem. 1960, 25, 899−
903.
(7) (a) Wang, Q.; Geng, H.; Chai, W.; Zeng, X.; Xu, M.; Zhu, C.; Fu,
R.; Yuan, R. Eur. J. Org. Chem. 2014, 31, 6850−6853. (b) Priyadarshini,
S.; Amal Joseph, P. J.; Lakshmi Kantam, M. RSC Adv. 2013, 3, 18283−
18287. (c) Liu, Z.-Q.; Zhao, L.; Shang, X.; Cui, Z. Org. Lett. 2012, 14,
3218−3221. (d) Kumar, G. S.; Pieber, B.; Reddy, K. R.; Kappe, C. O.
Chem.Eur. J. 2012, 18, 6124−6128.
(8) (a) Zhao, J.; Fang, H.; Zhou, W.; Han, J.; Pan, Y. J. Org. Chem.
2014, 79, 3847−3855. (b) Barve, B. D.; Wu, Y.-C.; El-Shazly, M.;
Korinek, M.; Cheng, Y.-B.; Wang, J.-J.; Chang, F.-R. Org. Lett. 2014,
16, 1912−1915.
(9) (a) Majji, G.; Rajamanickam, S.; Khatun, N.; Santra, S. K.; Patel,
B. K. J. Org. Chem. 2015, 80, 3440−3446. (b) Wang, Q.; Feng, J.; Chai,
W.; Geng, H.; Xu, M.; Wang, K.; Xu, C.; Fu, R.; Yuan, R. Tetrahedron
Lett. 2014, 55, 4785−4789. (c) Guo, S.; Yu, J.; Dai, Q.; Yang, H.;
Cheng, J. Chem. Commun. 2014, 50, 6240−6242. (d) Zhu, F.; Wang,
Z.-X. Tetrahedron 2014, 70, 9819. (e) Chen, L.; Shi, E.; Liu, Z.; Chen,
S.; Wei, W.; Li, H.; Xu, K.; Wan, X. Chem.Eur. J. 2011, 17, 4085−
4089.
(10) Zheng, Y.; Mao, J.; Rong, G.; Xu, X. Chem. Commun. 2015, 51,
8837−8840.
The Journal of Organic Chemistry Article
DOI: 10.1021/acs.joc.5b01043
J. Org. Chem. 2015, 80, 6814−6821
6820
(11) Cao, Q.; Dornan, L. M.; Rogan, L.; Hughes, N. L.; Muldoon, M.
J. Chem. Commun. 2014, 50, 4524−4543.
(12) (a) Debecker, D. P.; Hulea, V.; Mutin, P. H. Appl. Catal., A
2013, 451, 192−206. (b) Carpentier, J.; Lamonier, J.-F.; Siffert, S.;
Laversin, H.; Aboukaïs, A. In Stud. Surf. Sci. Catal.; Aiello, R.,
Giordano, G., Testa, F., Eds.; Elsevier Science B.V.: Taormina, 2002;
Vol. 142, pp 1197−1204.
(13) (a) García-Cabeza, A. L.; Marín-Barrios, R.; Moreno-Dorado, F.
J.; Ortega, M. J.; Massanet, G. M.; Guerra, F. M. Org. Lett. 2014, 16,
1598−1601. (b) García-Cabeza, A. L.; Marín-Barrios, R.; Azarken, R.;
Moreno-Dorado, F. J.; Ortega, M. J.; Vidal, H.; Gatica, J. M.; Massanet,
G. M.; Guerra, F. M. Eur. J. Org. Chem. 2013, 36, 8307−8314.
(14) Guida, A.; Lhouty, M. H.; Tichit, D.; Figueras, F.; Geneste, P.
Appl. Catal., A 1997, 164, 251−264.
(15) Wei, W.; Zhang, C.; Xu, Y.; Wan, X. Chem. Commun. 2011, 47,
10827−10829.
(16) Wang, C.-Y.; Song, R.-J.; Wei, W.-T.; Fan, J.-H.; Li, J.-H. Chem.
Commun. 2015, 51, 2361−2363.
(17) Zhao, J.; Zhou, W.; Han, J.; Li, G.; Pan, Y. Tetrahedron Lett.
2013, 54, 6507−6510.
(18) Müller, A.; Diemann, E. In Comprehensive Coordination
Chemistry; Wilkinson, G., Ed.; Pergamon: Oxford, 1987; Vol. 2, pp
515−550.
(19) (a) Yang, D.; Zhu, X.; Wei, W.; Sun, N.; Yuan, L.; Jiang, M.;
You, J.; Wang, H. RSC Adv. 2014, 4, 17832−17839. (b) Hudson, R.
Synlett 2013, 24, 1309−1310. (c) Hudson, R.; Ishikawa, S.; Li, C.-J.;
Moores, A. Synlett 2013, 24, 1637−1642. (d) Avudoddi, V.; Palle, V.
K. G.; Pallapothula, V. R. Eur. J. Chem. 2012, 3, 298−304.
(20) Newhouse, T.; Baran, P. S. Angew. Chem., Int. Ed. 2011, 50,
3362−3374.
(21) Müller, A.; Diemann, E. In Comprehensive Coordination
Chemistry; Wilkinson, G., Ed.; Pergamon: Oxford, 1987; Vol. 2, pp
551−558.
(22) Berkessel, A.; Vogl, N. In The Chemistry of Peroxides; Rappoport,
Z., Ed.; John Wiley and Sons: Chichester, 2006; Vol. 2, Part 1, pp
307−596.
(23) Liu, Y.-J.; Xu, H.; Kong, W.-J.; Shang, M.; Dai, H.-X.; Yu, J.-Q.
Nature 2014, 515, 389−393.
(24) Rodríguez-Carvajal, J. J. Phys. B (Amsterdam, Neth.) 1993, 192,
55−69.
The Journal of Organic Chemistry Article
DOI: 10.1021/acs.joc.5b01043
J. Org. Chem. 2015, 80, 6814−6821
6821
